{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:01:38Z","timestamp":1780992098467,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":131,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02609","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:52:11Z","timestamp":1778763131000},"page":"e02609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BCG gone rogue: A case report of disseminated Mycobacterium bovis"],"prefix":"10.1016","volume":"44","author":[{"given":"Youssef","family":"Saklawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann Kirkconnell","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hady","family":"Samaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02609_bib1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","article-title":"Can intravesical bacillus Calmette-Gu\u00e9rin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials","volume":"67","author":"Han","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.idcr.2026.e02609_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6230409","article-title":"Clinical spectrum of complications induced by intravesical immunotherapy of bacillus calmette-gu\u00e9rin for bladder cancer","volume":"2019","author":"Liu","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.idcr.2026.e02609_bib3","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.idcr.2026.e02609_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urolonc.2020.11.037","article-title":"BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: a systematic review","volume":"39","author":"Cabas","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.idcr.2026.e02609_bib5","doi-asserted-by":"crossref","first-page":"21.e21","DOI":"10.1016\/j.urolonc.2023.09.010","article-title":"Bacillus Calmette-Guerin (BCG) therapy is safe and effective in non-muscle invasive bladder cancer (NMIBC) patients with immunomodulating conditions","volume":"42","author":"Durant","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.idcr.2026.e02609_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/20009666.2020.1742475","article-title":"Disseminated BCG sepsis following intravesical therapy for bladder carcinoma: a case report and review of literature","volume":"10","author":"Oladiran","year":"2020","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.idcr.2026.e02609_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.idc.2007.08.001","article-title":"Fever of unknown origin caused by tuberculosis","volume":"21","author":"Bofinger","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idcr.2026.e02609_bib8","first-page":"189","article-title":"False positive hepatitis B surface antigen due to recent vaccination","volume":"8","author":"Anjum","year":"2014","journal-title":"Int J Health Sci (Qassim)"},{"key":"10.1016\/j.idcr.2026.e02609_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkv419","article-title":"1,3-\u03b2-D-glucan contamination of common antimicrobials","volume":"71","author":"Liss","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2026.e02609_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.idcr.2026.e02609_bib11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.5588\/ijtld.17.0326","article-title":"TB-PCR and drug resistance pattern in BALF in smear-negative active pulmonary TB","volume":"21","author":"Chavalertsakul","year":"2017","journal-title":"Int J Tube Lung Dis"},{"key":"10.1016\/j.idcr.2026.e02609_bib12","article-title":"Disseminated mycobacterium bovis infection: a rare complication of bacillus calmette-gu\u00e9rin immunotherapy","volume":"15","author":"Henriques Mendes","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.idcr.2026.e02609_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.idcr.2026.e02609_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.22374\/cjgim.v14i2.283","article-title":"Disseminated mycobacterium sepsis with bone marrow, liver, and lung involvement following intravesical bacillus calmette-Guerin (BCG) therapy","volume":"14","author":"Hager","year":"2019","journal-title":"Can J Gen Intern Med"},{"key":"10.1016\/j.idcr.2026.e02609_bib15","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of mycobacterium bovis bacille calmette-gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02609_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.idcr.2026.e02609_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/iju.13538","article-title":"Bacillus Calmette-Gu\u00e9rin strain differences as the basis for immunotherapies against bladder cancer","volume":"25","author":"Miyazaki","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.idcr.2026.e02609_bib18","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1016\/j.vaccine.2021.08.026","article-title":"A BCG success story: from prevention of tuberculosis to optimal bladder cancer treatment","volume":"39","author":"Lamm","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.idcr.2026.e02609_bib19","unstructured":"BCG vaccine for intravesical use [Package insert]. 2009. Accessed: https:\/\/www.fda.gov\/media\/76396\/download?attachment."},{"key":"10.1016\/j.idcr.2026.e02609_bib20","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(25)01897-5","article-title":"Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial","volume":"406","author":"De Santis","year":"2025","journal-title":"Lancet"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:50:05Z","timestamp":1780991405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"alternative-id":["S2214250926001228"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02609","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG gone rogue: A case report of disseminated Mycobacterium bovis","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02609"}}